APOB and familial hypercholesterolemia: Gain-of-function mutations in PCSK9 are linked to elevated plasma LDL cholesterol levels and constitute a third genetic cause of familial hypercholesterolemia, alongside mutations affecting the LDL receptor and apolipoprotein B (apoB) [14].